Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanomaMichele Del Vecchio, Michele Maio, Lorenza Di Guardo et al.|European Journal of Cancer|2013Cited by 157
Real-World Study of Everolimus in Advanced Progressive Neuroendocrine TumorsFrancesco Panzuto, Gianfranco Delle Fave, Maria Rinzivillo et al.|The Oncologist|2014Cited by 103
Dramatic Regression of Multiple Brain Metastases from Breast Cancer with Capecitabine: Another Arrow at the Bow?Alessandra Fabi, F. Cognetti, Antonello Vidiri et al.|Cancer Investigation|2006Cited by 42
Is Recurrent Venous Thromboembolism After Therapy Reduced by Low-Molecular-Weight Heparin Compared With Oral Anticoagulants?G. Ferretti, F. Cognetti, Emilio Bria et al.|CHEST Journal|2006Cited by 41
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trialsG. Ferretti, Paolo Carlini, Emilio Bria et al.|British Journal of Cancer|2006Cited by 38